查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1888581

全球 C 反應蛋白檢測市場：市場規模、佔有率、趨勢分析（按檢測方法、檢測範圍、疾病、最終用途和地區分類）、細分市場預測（2025-2033 年）

C-Reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay (ELISA, CLIA), By Detection Range (hs-CRP, Conventional CRP), By Disease (Cardiovascular Diseases, Cancer), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

C反應蛋白檢測市場概覽

2024 年全球 C 反應蛋白檢測市場規模預計為 52.7 億美元，預計到 2033 年將達到 60.8 億美元，2025 年至 2033 年的複合年成長率為 1.64%，這主要得益於對精準醫療日益成長的需求。

C反應蛋白是一種急性期反應物，其水平在疾病早期升高，並引起體內發炎。

心血管疾病、糖尿病和自體免疫疾病等慢性病的日益增多是推動該市場發展的主要因素。此外，CRP檢測技術的進步，例如診斷技術的創新、檢測準確性的提高以及檢測的便利性，也是推動該市場發展的主要因素。

照護現場檢測（POC​​）C反應蛋白（CRP）技術的發展徹底改變了疾病診斷方式，使得在診所、藥房甚至居家醫療環境中進行快速現場檢測成為可能。這些進步縮短了檢測結果的周轉時間，並加快了臨床決策，從而提高了醫療服務的效率。隨著個人化醫療需求的日益成長，CRP檢測技術的進步有望透過改善患者預後和簡化診斷流程，進一步推動市場成長。根據2024年7月的報告，康乃爾大學提出了一種基於電化學阻抗電阻（EIS）的感測器，該感測器提案微創微針陣列，可即時、快速、靈敏地檢測組織間液（ISF）中的C反應蛋白（CRP）。這種感測器可以整合到類似於連續血糖監測的穿戴式設備中，為CRP檢測提供一種非侵入性、經濟、便利的方法。

C反應蛋白（CRP）檢測是早期診斷感染疾病、心血管疾病和發炎性疾病的重要工具，有助於及時進行醫療干預。世界各國政府和醫療機構都在積極推廣常規篩檢項目，以便在出現嚴重併發症之前發現高風險族群。此外，個人健康意識的不斷提高也推動了對預防性診斷檢測（例如CRP檢測）的需求，使其成為常規健康檢查的一部分。這種向預防性護理和疾病早期檢測的轉變是推動CRP檢測市場發展的關鍵因素。隨著醫療系統優先考慮降低長期治療成本和改善患者預後，早期發現發炎相關疾病變得日益重要。對主動健康管理的日益重視將進一步加速CRP檢測在各種醫療機構中的應用。

新興市場對C反應蛋白（CRP）檢測的接受度和應用範圍不斷擴大，是推動CRP檢測市場擴張的關鍵因素之一。由於生活方式的改變、都市化的加速以及人口老化，慢性病在這些地區日益普遍，因此對價格合理且易於獲取的診斷解決方案的需求也日益成長。 CRP檢測正逐漸成為初級保健篩檢的常規項目，尤其是在感染疾病和發炎性疾病高發生率地區。診斷檢測服務的擴展，以及農村和就地檢驗的普及，預計將進一步推動這些地區的市場發展。隨著新興市場醫療保健體系的不斷發展，對CRP檢測的需求將持續成長，從而推動全球市場的成長。

除了技術進步之外，CRP檢測在臨床研究中也持續發揮重要作用。例如，2024年8月在歐洲心臟學會發表的一項研究利用高敏感性CRP（hsCRP）檢測評估女性心血管風險。研究結果表明，評估30歲左右人群的hsCRP水平可以更準確地預測未來心血管事件，凸顯了早期療育和個人化醫療策略的重要性。這些進展表明CRP檢測具有動態發展潛力，並反映出其在市場成長和臨床實踐中日益重要的作用。

目錄

第1章 分析方法和範圍

第2章執行摘要

3. C反應蛋白檢測市場：促進因素、趨勢與範圍

  • 市場概覽/關係展望
  • 市場動態
  • C反應蛋白檢測市場：分析工具
    • 波特五力分析
    • PESTEL 分析

第4章 C反應蛋白檢測市場：依檢測方法分類的估算與趨勢分析

  • C反應蛋白（CRP）檢測市場：依檢測方法分類的差異分析
  • 檢測法
    • 免疫比濁法檢測法市場（2021-2033）
  • ELISA
    • ELISA市場（2021-2033年）
    • 臨床 ELISA
    • 非臨床 ELISA
  • 化學冷光免疫檢測
    • 化學冷光免疫檢測市場（2021-2033）
  • 其他
    • 其他市場（2021-2033 年）

第5章 C反應蛋白檢測市場：依檢測範圍分類的估算與趨勢分析

  • C反應蛋白（CRP）檢測市場：依檢測範圍分類的差異分析
  • 高敏感性C反應蛋白（hs-CRP）
    • 高敏感性C反應蛋白（hs-CRP）市場（2021-2033年）
  • 傳統CRP
    • 傳統CRP市場（2021-2033年）
  • 心臟C反應蛋白（cCRP）
    • 心臟 C 反應蛋白 (cCRP) 市場 (2021-2033)

第6章：C反應蛋白檢測市場：依疾病區分的估算與趨勢分析

  • C反應蛋白（CRP）檢測市場：依疾病分類的差異分析
  • 心血管疾病
    • 心血管疾病市場（2021-2033）
  • 癌症
    • 癌症市場（2021-2033）
  • 類風濕性關節炎
    • 類風濕性關節炎市場（2021-2033）
  • 發炎性腸道疾病
    • 發炎性腸道疾病市場（2021-2033）
  • 子宮內膜異位症
    • 子宮內膜異位症市場（2021-2033）
  • 狼瘡
    • 狼瘡市場（2021-2033）
  • 其他
    • 其他市場（2021-2033 年）

7. C反應蛋白檢測市場：依最終用途分類的估算與趨勢分析

  • C反應蛋白（CRP）檢測市場：依最終用途分類的差異分析
  • 診所
    • 診所市場（2021-2033 年）
    • 診所：按機構
    • 診所：依安裝類型分類
  • 醫院
    • 醫院市場（2021-2033 年）
    • 都市區
    • 鄉村環境
  • 研究所
    • 實驗室市場（2021-2033）
    • 都市區
    • 鄉村環境
  • 老年人照護住宅
    • 老年人輔助住宅市場（2021-2033）
    • 都市區
    • 鄉村環境
  • 居家醫療
    • 居家醫療市場（2021-2033 年）
  • 其他
    • 其他市場（2021-2033 年）

第8章：C反應蛋白檢測市場：區域估算與趨勢分析

  • C反應蛋白檢測市場佔有率（按地區分類，2024年和2033年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司分類
  • 公司熱力圖分析
  • 公司簡介
  • Abbott
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
  • Siemens Healthineers AG
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
  • Danaher Corporation
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
  • Quest Diagnostics
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
  • Getein Biotech, Inc
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
  • Merck KGaAA
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
  • Zoetis
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
  • F. Hoffmann-La Roche AG
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
  • Ortho Clinical Diagnostics
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
  • Thermo Fisher Scientific, Inc.
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
  • HORIBA, Ltd
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
  • Randox Laboratories Ltd.
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
  • Boditech Med, Inc.
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
  • Aidian
    • 參與企業概況
    • 財務業績
    • 產品基準化分析
    • 最新趨勢/策略舉措
Product Code: GVR-2-68038-129-0

C-Reactive Protein Testing Market Summary

The global C-reactive protein testing market size was estimated at USD 5.27 billion in 2024, and is projected to reach USD 6.08 billion by 2033, growing at a CAGR of 1.64% from 2025 to 2033, due to the increasing demand for precision medicine. C-reactive protein is an acute-phase reactant whose levels rise during the early stage of a disease condition, leading to inflammation in the body.

The increasing burden of chronic diseases such as cardiovascular disorders, diabetes, and autoimmune conditions is a major driver of the market. In addition, technological advancements in CRP testing, such as innovations in diagnostic techniques, accuracy of the tests, and ease of accessibility contribute to the major drivers for this market.

The development of point-of-care (POC) CRP testing has transformed disease diagnosis by allowing for quick, on-site testing in clinics, pharmacies, and even home-care environments. These advancements have improved the efficiency of healthcare delivery by shortening result turnaround times and facilitating quicker clinical decision-making. As the demand for personalized medicine increases, technological advancements in CRP testing are anticipated to further propel market growth by enhancing patient outcomes and streamlining diagnostic procedures. According to a report in July 2024, Cornell University proposed an electrochemical impedance spectroscopy (EIS)-based sensor for real-time, fast, and sensitive detection of C-reactive protein (CRP) in interstitial fluid (ISF) using minimally invasive microneedle arrays. This sensor, which could be integrated into a wearable device similar to continuous glucose monitoring, offers a non-invasive, affordable, and simple method for CRP detection.

CRP testing serves as an essential tool for early diagnosis of infections, cardiovascular conditions, and inflammatory disorders, allowing for timely medical intervention. Governments and healthcare organizations around the globe are actively encouraging regular screening programs to detect individuals at risk before serious complications develop. In addition, growing health awareness among individuals has resulted in a higher demand for preventive diagnostic tests, such as CRP testing, as part of regular health check-ups. The shift towards preventive healthcare and early disease detection has been a key factor driving the CRP testing market. As healthcare systems prioritize lowering long-term treatment expenses and enhancing patient outcomes, the early detection of inflammation-related diseases has become increasingly crucial. The increasing focus on proactive health management will further accelerate the adoption of CRP testing in various healthcare settings.

One of the key drivers for expansion in the market for C reactive protein testing is the increasing adoption of these tests and expanding their application in emerging markets. As chronic diseases become more prevalent in these regions due to lifestyle changes, urbanization, and aging populations, the demand for affordable and accessible diagnostic solutions is growing. CRP testing is becoming a standard component of primary healthcare screenings, especially in regions with high rates of infectious diseases and inflammatory disorders. The expansion of diagnostic laboratory services, along with the growing availability of point-of-care testing in rural and underserved areas, is expected to further drive the market in these regions. As healthcare systems in emerging markets continue to advance, the demand for CRP testing will continue to rise, fueling global market growth.

Beyond technological advancements, CRP testing continues to be integral in clinical research applications. For example, in August 2024, a study presented at the European Society of Cardiology Companies utilized hsCRP (high sensitive) measurements to assess cardiovascular risks in women. The findings suggest that evaluating hsCRP levels starting in a woman's 30s can better predict future cardiovascular events, highlighting the importance of early intervention and personalized healthcare strategies. These developments underscore the dynamic nature of CRP testing, reflecting its expanding role in both market growth and clinical practice.

Global C-Reactive Protein Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global C-reactive protein testing market report based on assay, detection range, disease, end use, and region:

  • Assay Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunoturbidimetric Assay
  • ELISA
    • Clinical
    • Nonclinical
  • Chemiluminescence Immunoassay
  • Others
  • Detection Range Outlook (Revenue, USD Million, 2021 - 2033)
  • hs-CRP
  • Conventional CRP
  • cCRP
  • Disease Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiovascular Diseases
  • Cancer
  • Rheumatoid Arthritis
  • Inflammatory Bowel Disease
  • Endometriosis
  • Lupus
  • Others
  • End use Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinics
    • By Entity
    • Physician Offices
    • Small Clinics
    • Others
    • By Settings
    • Urban Setting
    • Rural Setting
  • Hospitals
    • Urban Setting
    • Rural Setting
  • Laboratories
    • Urban Setting
    • Rural Setting
  • Assisted Living Healthcare Facilities
    • Urban Setting
    • Rural Setting
  • Home
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Assay
    • 1.2.2. Detection Range
    • 1.2.3. Disease
    • 1.2.4. End Use
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. C-Reactive Protein Testing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising incidence of chronic and infectious diseases
      • 3.3.1.2. Increasing demand for point-of-care diagnostics
      • 3.3.1.3. Growing demand for portable and automated C-reactive proteins
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Lower detection limit
      • 3.3.2.2. Limitations associated with C-reactive protein techniques
  • 3.4. C-Reactive Protein Testing Market Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. C-Reactive Protein Testing Market: Assay Estimates & Trend Analysis

  • 4.1. C-reactive Protein (CRP) Testing Market: Assay Movement Analysis
  • 4.2. Immunoturbidimetric Assay
    • 4.2.1. Immunoturbidimetric Assay Market, 2021 - 2033 (USD Million)
  • 4.3. ELISA
    • 4.3.1. ELISA Market, 2021 - 2033 (USD Million)
    • 4.3.2. Clinical ELISA
      • 4.3.2.1. Clinical ELISA Market, 2021 - 2033 (USD Million)
    • 4.3.3. Nonclinical ELISA
      • 4.3.3.1. Nonclinical ELISA Market, 2021 - 2033 (USD Million)
  • 4.4. Chemiluminescence Immunoassay
    • 4.4.1. Chemiluminescence Immunoassay Market, 2021 - 2033 (USD Million)
  • 4.5. Others
    • 4.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. C-Reactive Protein Testing Market: Detection Range Estimates & Trend Analysis

  • 5.1. C-reactive Protein (CRP) Testing Market: Detection Range Movement Analysis
  • 5.2. High Sensitivity C-reactive Protein (hs-CRP)
    • 5.2.1. High Sensitivity C-reactive Protein (hs-CRP) Market, 2021 - 2033 (USD Million)
  • 5.3. Conventional CRP
    • 5.3.1. Conventional CRP Market, 2021 - 2033 (USD Million)
  • 5.4. Cardiac CRP (cCRP)
    • 5.4.1. Cardiac CRP (CCRP) Market, 2021 - 2033 (USD Million)

Chapter 6. C-Reactive Protein Testing Market Disease Estimates & Trend Analysis

  • 6.1. C-reactive Protein (CRP) Testing Market: Disease Movement Analysis
  • 6.2. Cardiovascular Diseases
    • 6.2.1. Cardiovascular Diseases Market, 2021 - 2033 (USD Million)
  • 6.3. Cancer
    • 6.3.1. Cancer Market, 2021 - 2033 (USD Million)
  • 6.4. Rheumatoid Arthritis
    • 6.4.1. Rheumatoid Arthritis Market, 2021 - 2033 (USD Million)
  • 6.5. Inflammatory Bowel Disease
    • 6.5.1. Inflammatory Bowel Disease Market, 2021 - 2033 (USD Million)
  • 6.6. Endometriosis
    • 6.6.1. Endometriosis Market, 2021 - 2033 (USD Million)
  • 6.7. Lupus
    • 6.7.1. Lupus Market, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. C-Reactive Protein Testing Market End Use Estimates & Trend Analysis

  • 7.1. C-reactive Protein (CRP) Testing Market: End Use Movement Analysis
  • 7.2. Clinics
    • 7.2.1. Clinics Market, 2021 - 2033 (USD Million)
    • 7.2.2. Clinics, by entity
      • 7.2.2.1. Physician offices
        • 7.2.2.1.1. Physician Offices Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Small clinics
        • 7.2.2.2.1. Small Clinics Market, 2021 - 2033 (USD Million)
      • 7.2.2.3. Others
        • 7.2.2.3.1. Others Market, 2021 - 2033 (USD Million)
    • 7.2.3. Clinics, by setting
      • 7.2.3.1. Urban setting
        • 7.2.3.1.1. Urban Setting Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Rural settings
        • 7.2.3.2.1. Rural Settings Market, 2021 - 2033 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market, 2021 - 2033 (USD Million)
    • 7.3.2. Urban setting
      • 7.3.2.1. Urban Setting Market, 2021 - 2033 (USD Million)
    • 7.3.3. Rural settings
      • 7.3.3.1. Rural Settings Market, 2021 - 2033 (USD Million)
  • 7.4. Laboratories
    • 7.4.1. Laboratories Market, 2021 - 2033 (USD Million)
    • 7.4.2. Urban setting
      • 7.4.2.1. Urban Setting Market, 2021 - 2033 (USD Million)
    • 7.4.3. Rural settings
      • 7.4.3.1. Rural Settings Market, 2021 - 2033 (USD Million)
  • 7.5. Assisted Living Healthcare Facilities
    • 7.5.1. Assisted Living Healthcare Facilities Market, 2021 - 2033 (USD Million)
    • 7.5.2. Urban setting
      • 7.5.2.1. Urban Setting Market, 2021 - 2033 (USD Million)
    • 7.5.3. Rural settings
      • 7.5.3.1. Rural Settings Market, 2021 - 2033 (USD Million)
  • 7.6. Home
    • 7.6.1. Home Market, 2021 - 2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. C-Reactive Protein Testing Market: Regional Estimates & Trend Analysis

  • 8.1. C-Reactive Protein Testing Market Share, By Region, 2024 & 2033 (USD Million)
  • 8.2. North America
    • 8.2.1. North America C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Target Disease Prevalence
      • 8.2.2.3. Competitive Scenario
      • 8.2.2.4. Regulatory Framework
      • 8.2.2.5. Reimbursement Scenario
      • 8.2.2.6. U.S. C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Reimbursement Scenario
      • 8.2.3.6. Canada C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Reimbursement Scenario
      • 8.2.4.6. Mexico C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. Reimbursement Scenario
      • 8.3.2.6. UK C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Reimbursement Scenario
      • 8.3.3.6. Germany C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Reimbursement Scenario
      • 8.3.4.6. France C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Reimbursement Scenario
      • 8.3.5.6. Italy C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Reimbursement Scenario
      • 8.3.6.6. Spain C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Reimbursement Scenario
      • 8.3.7.6. Denmark C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Reimbursement Scenario
      • 8.3.8.6. Sweden C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Reimbursement Scenario
      • 8.3.9.6. Norway C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Reimbursement Scenario
      • 8.4.2.6. Japan C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Reimbursement Scenario
      • 8.4.3.6. China C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. Reimbursement Scenario
      • 8.4.4.6. India C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Reimbursement Scenario
      • 8.4.5.6. Australia C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Reimbursement Scenario
      • 8.4.6.6. South Korea C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Reimbursement Scenario
      • 8.4.7.6. Thailand C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Reimbursement Scenario
      • 8.5.2.6. Brazil C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Reimbursement Scenario
      • 8.5.3.6. Argentina C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. Reimbursement Scenario
      • 8.6.2.6. South Africa C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Reimbursement Scenario
      • 8.6.3.6. Saudi Arabia C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Reimbursement Scenario
      • 8.6.4.6. UAE C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Reimbursement Scenario
      • 8.6.5.6. Kuwait C-Reactive Protein Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
  • 9.5. Abbott
    • 9.5.1. Participant's Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Developments/ Strategic Initiatives
  • 9.6. Siemens Healthineers AG
    • 9.6.1. Participant's Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Developments/ Strategic Initiatives
  • 9.7. Danaher Corporation
    • 9.7.1. Participant's Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Developments/ Strategic Initiatives
  • 9.8. Quest Diagnostics
    • 9.8.1. Participant's Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Developments/ Strategic Initiatives
  • 9.9 Getein Biotech, Inc
    • 9.8.5. Participant's Overview
    • 9.8.6. Financial Performance
    • 9.8.7. Product Benchmarking
    • 9.8.8. Recent Developments/ Strategic Initiatives
  • 9.10. Merck KGaAA
    • 9.10.1. Participant's Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Developments/ Strategic Initiatives
  • 9.11. Zoetis
    • 9.11.1. Participant's Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Developments/ Strategic Initiatives
  • 9.12. F. Hoffmann-La Roche AG
    • 9.12.1. Participant's Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Developments/ Strategic Initiatives
  • 9.13. Ortho Clinical Diagnostics
    • 9.13.1. Participant's Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Developments/ Strategic Initiatives
  • 9.14. Thermo Fisher Scientific, Inc.
    • 9.14.1. Participant's Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Developments/ Strategic Initiatives
  • 9.15. HORIBA, Ltd
    • 9.15.1. Participant's Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Developments/ Strategic Initiatives
  • 9.16. Randox Laboratories Ltd.
    • 9.16.1. Participant's Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Developments/ Strategic Initiatives
  • 9.17. Boditech Med, Inc.
    • 9.17.1. Participant's Overview
    • 9.17.2. Financial Performance
    • 9.17.3. Product Benchmarking
    • 9.17.4. Recent Developments/ Strategic Initiatives
  • 9.18. Aidian
    • 9.18.1. Participant's Overview
    • 9.18.2. Financial Performance
    • 9.18.3. Product Benchmarking
    • 9.18.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global C-reactive protein market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 4 Global C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 5 Global C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 6 Global C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 7 North America C-reactive protein market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 9 North America C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 10 North America C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 11 North America C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 12 U.S. C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 13 U.S. C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 14 U.S. C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 15 U.S. C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 16 Canada C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 17 Canada C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 18 Canada C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 19 Canada C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 20 Mexico C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 21 Mexico C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 22 Mexico C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 23 Mexico C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 24 Europe C-reactive protein market, by country, 2021 - 2033 (USD Million)
  • Table 25 Europe C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 26 Europe C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 27 Europe C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 28 Europe C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 29 UK C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 30 UK C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 31 UK C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 32 UK C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 33 Germany C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 34 Germany C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 35 Germany C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 36 Germany C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 37 France C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 38 France C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 39 France C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 40 France C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 41 Italy C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 42 Italy C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 43 Italy C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 44 Italy C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 45 Spain C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 46 Spain C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 47 Spain C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 48 Spain C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 49 Denmark C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 50 Denmark C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 51 Denmark C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 52 Denmark C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 53 Sweden C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 54 Sweden C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 55 Sweden C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 56 Sweden C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 57 Norway C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 58 Norway C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 59 Norway C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 60 Norway C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific C-reactive protein market, by country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 66 Japan C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 67 Japan C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 68 Japan C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 69 Japan C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 70 China C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 71 China C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 72 China C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 73 China C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 74 India C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 75 India C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 76 India C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 77 India C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 78 Australia C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 79 Australia C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 80 Australia C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 81 Australia C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 82 South Korea C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 83 South Korea C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 84 South Korea C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 85 South Korea C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 86 Thailand C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 87 Thailand C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 88 Thailand C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 89 Thailand C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 90 Latin America C-reactive protein market, by country, 2021 - 2033 (USD Million)
  • Table 91 Latin America C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 92 Latin America C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 93 Latin America C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 94 Latin America C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 95 Brazil C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 96 Brazil C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 97 Brazil C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 98 Brazil C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 99 Argentina C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 100 Argentina C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 101 Argentina C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 102 Argentina C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 103 MEA C-reactive protein market, by country, 2021 - 2033 (USD Million)
  • Table 104 MEA C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 105 MEA C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 106 MEA C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 107 MEA C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 108 South Africa C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 109 South Africa C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 110 South Africa C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 111 South Africa C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 116 UAE C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 117 UAE C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 118 UAE C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 119 UAE C-reactive protein market, by end-use, 2021 - 2033 (USD Million)
  • Table 120 Kuwait C-reactive protein market, by assay, 2021 - 2033 (USD Million)
  • Table 121 Kuwait C-reactive protein market, by disease, 2021 - 2033 (USD Million)
  • Table 122 Kuwait C-reactive protein market, by detection range, 2021 - 2033 (USD Million)
  • Table 123 Kuwait C-reactive protein market, by end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 C-reactive protein testing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot - 1
  • Fig. 14 Segment snapshot - 2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 C-reactive protein testing market: Assay outlook key takeaways
  • Fig. 20 C-reactive protein testing market: Assay movement analysis
  • Fig. 21 Immunoturbidimetric assay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 ELISA market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Chemiluminescence Immunoassay (CLIA ) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Other Reagents & Kits market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 C-reactive protein market: Detection Range outlook key takeaways
  • Fig. 26 C-reactive protein market: Detection Range movement analysis
  • Fig. 27 hs-CRP market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Conventional CRP market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 cCRP market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 C-reactive protein market: Disease outlook key takeaways
  • Fig. 31 C-reactive protein market: Disease movement analysis
  • Fig. 32 Cardiovascular diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Cancer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Rheumatoid arthritis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Inflammatory bowel disease Testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Endometriosis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Lupus market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 C-reactive protein market: End Use outlook key takeaways
  • Fig. 40 C-reactive protein market: End Use movement analysis
  • Fig. 41 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Physician Office clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Small clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Others clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Assisted living healthcare facilities market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Home market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Regional marketplace outlook, 2024 & 2033 (USD Million)
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 North America C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 U.S. C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Canada C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Mexico C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Europe C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 UK C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Germany C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 France C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Spain C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Italy C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Denmark C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Sweden C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Norway C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Asia Pacific C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Japan C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 China C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 India C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Australia C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 South Korea C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Thailand C-reactive protein testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Market participant categorization
  • Fig. 91 C-reactive protein testing market position analysis, 2024
  • Fig. 92 Strategic framework